Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial. (2023)
Attributed to:
MRC Strategic Award to establish an International Centre for Genomic Medicine in Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1212/wnl.0000000000207402
PubMed Identifier: 37268435
Publication URI: http://europepmc.org/abstract/MED/37268435
Type: Journal Article/Review
Volume: 101
Parent Publication: Neurology
Issue: 3
ISSN: 0028-3878